Roderic

Roderick MacKinnon was born on February 19, 1956, in Burlington, Massachusetts, a town on the outskirts of Boston, and grew up there as one of seven children ^[1]. His parents encouraged curiosity without pushing any particular career, and he later recalled a childhood spent outdoors and an early fascination with how things worked rather than with formal schooling ^[1].

As a teenager he developed an interest in science that sharpened during his undergraduate years. He began college at the University of Massachusetts Boston before transferring to Brandeis University in Waltham, where he completed a degree in biochemistry in 1978 ^[2]. At Brandeis he worked in the laboratory of Christopher Miller, a biophysicist studying ion channels, the pore forming proteins that let charged atoms cross cell membranes. That undergraduate encounter planted a question that would occupy most of his working life: how do these tiny molecular gates select which ions to admit ^[2]?

Rather than proceeding directly to a research doctorate, MacKinnon chose medical school. He earned his MD from Tufts University School of Medicine in Boston in 1982, then completed a residency in internal medicine at Beth Israel Hospital ^[1]. For a time he practiced as an internist, and the clinical years gave him a working knowledge of physiology that few structural biologists possess.

Medicine, however, did not satisfy him. In 1986 he made an unusual decision for a thirty year old physician: he walked away from clinical practice and returned to Christopher Miller's laboratory at Brandeis as a postdoctoral researcher, despite holding no PhD ^[2]. There he studied how scorpion venom toxins block potassium channels, work that provided some of the first functional maps of a channel's outer mouth ^[3]. Anyone asking who was Roderic MacKinnon before his fame would find the answer in these years: a former doctor retraining himself, bench by bench, in biophysics.

In 1989 he joined the faculty of Harvard Medical School, where his group used electrophysiology and mutagenesis to probe channel behavior one amino acid at a time ^[1]. A key result from this period showed that the potassium channel is built from four identical subunits arranged around a central pore, a deduction made entirely from functional experiments before any structure existed ^[3].

By the mid 1990s MacKinnon had concluded that indirect methods could carry the field no further. Understanding ion selectivity, the puzzle of how a channel passes potassium ions ten thousand times more readily than smaller sodium ions, required seeing the protein itself. So he resolved to learn X-ray crystallography, a demanding discipline in which he had no formal training ^[1]. In 1996 he left Harvard for Rockefeller University in New York City, which offered him the freedom to attempt what many colleagues considered close to impossible: crystallizing a membrane protein channel ^[4].

The gamble paid off quickly. In 1998 his laboratory published the structure of KcsA, a bacterial potassium channel, in the journal Science ^[5]. The images explained selectivity with startling clarity. Oxygen atoms lining a narrow selectivity filter mimic the water shell that normally surrounds a potassium ion, allowing the ion to shed its water and slip through, while sodium ions, too small to fit the arrangement snugly, are excluded ^[5]. The structure confirmed predictions made decades earlier from electrical measurements and gave physiology one of its most satisfying molecular explanations.

MacKinnon's group followed with a series of further structures: chloride channels, a calcium gated potassium channel, and in 2003 a voltage dependent potassium channel that revealed how channels sense the electrical field across a membrane ^[4]. Among Roderic MacKinnon achievements, this sustained sequence of firsts transformed ion channels from electrical abstractions into visible machines.

Recognition arrived rapidly. In 1999 MacKinnon shared the Albert Lasker Basic Medical Research Award with Clay Armstrong and Bertil Hille for work on ion channels ^[6]. He was elected to the National Academy of Sciences in 2000 and named an investigator of the Howard Hughes Medical Institute in 1997, a position that has funded his laboratory ever since ^[4].

The capstone came in October 2003, when the Royal Swedish Academy of Sciences awarded him half of the Nobel Prize in Chemistry for structural and mechanistic studies of ion channels. He shared the prize with Peter Agre of Johns Hopkins University, who was honored for discovering aquaporins, the channels that conduct water ^[7]. At forty seven, only five years removed from the KcsA structure, MacKinnon had received science's most visible award for work of unusual recency, a mark of how decisively the structures had settled old questions ^[7].

Other honors followed, including the Gairdner International Award and the Perl-UNC Neuroscience Prize, and any list of Roderic facts now begins with the Nobel, though colleagues often point instead to his habit of doing key experiments with his own hands well into seniority ^[4].

MacKinnon married Alka Agrawal, a scientist who has worked alongside him and managed aspects of his laboratory at Rockefeller ^[1]. The two have collaborated closely for decades, and he has credited her support during the intense years of the potassium channel work, when the laboratory sometimes operated around the clock at synchrotron beamlines ^[1].

Outside the laboratory he is known for physical pursuits, including cycling and surfing, interests that later fed directly back into his research when his group turned to the mechanosensitive Piezo channels that convert pressure and touch into electrical signals ^[8]. Colleagues describe him as reserved in public and relentless at the bench, a scientist who prefers experiments to administration and has declined the institutional leadership roles that often follow a Nobel ^[4].

MacKinnon remains head of the Laboratory of Molecular Neurobiology and Biophysics at Rockefeller University, where he holds the John D. Rockefeller Jr. Professorship ^[4]. Since the Nobel his group has broadened its scope, adopting cryo-electron microscopy to capture structures of mechanosensitive and lipid gated channels that resisted crystallization, including Piezo1, the sensor implicated in touch, blood pressure regulation, and red blood cell volume ^[8].

The practical reach of the work is wide. Ion channels are the targets of drugs for epilepsy, cardiac arrhythmia, chronic pain, and hypertension, and rational design of such medicines depends on the structural framework his laboratory established ^[7]. Textbooks of physiology and biochemistry now reproduce the KcsA selectivity filter as a standard illustration of protein function.

Any Roderic MacKinnon biography ultimately tells a story about scientific risk: a physician without a doctorate who retrained twice, first in biophysics and then in crystallography, and each time answered a question others thought out of reach ^[1]. His example is cited within structural biology as an argument for letting a single sharp question, rather than a fixed set of techniques, define a career ^[4].